Patents by Inventor Moshe Flashner

Moshe Flashner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6632451
    Abstract: A two pulse gastrointestinal delivery system is provided. The system comprises a desired agent in combination with a swellable core material, the core being surrounded by an inner coat of a water-insoluble or relatively water-insoluble coating material in which particulate water-insoluble material is embedded. The inner coat is additionally surrounded by an outer coat that contains additional amounts of the desired agent. When the delivery device enters the gastrointestinal tract, the outer coat releases the desired agent contained therein and disintegrates, exposing the inner coat. The particulate matter in the inner coat takes up liquid, thus forming channels interconnecting the drug-containing core with the outside of the delivery device. Through these channels liquid enters the core which then swells to the point at which the inner coat is broken. When the integrity of the inner coat is destroyed, the core then disintegrates, immediately releasing all or most of the drug at a specific site.
    Type: Grant
    Filed: June 4, 1999
    Date of Patent: October 14, 2003
    Assignee: Dexcel Pharma Technologies Ltd.
    Inventors: Adel Penhasi, Moshe Flashner, E. Itzhak Lerner
  • Patent number: 6531152
    Abstract: A gastrointestinal delivery system is provided. The system comprises a drug in combination with a swellable core material, the core being surrounded by a water-insoluble or relatively water-insoluble coating material in which particulate water-insoluble material is embedded. When the delivery device enters the gastrointestinal tract, the particulate matter takes up liquid, thus forming channels interconnecting the drug-containing core with the outside of the delivery device. Through these channels liquid enters the core which then swells to the point at which the coating is broken. When the integrity of the coating is destroyed, the core then disintegrates immediately releasing all or most of the drug at a specific site. By controlling parameters in the device, such as the core material, carrier material in the coating, and particulate matter, the location of release of the drug can be carefully controlled.
    Type: Grant
    Filed: October 24, 2000
    Date of Patent: March 11, 2003
    Assignee: Dexcel Pharma Technologies Ltd.
    Inventors: E. Itzhak Lerner, Moshe Flashner, Adel Penhasi
  • Publication number: 20020110593
    Abstract: A two pulse gastrointestinal delivery system is provided. The system comprises a desired agent in combination with a swellable core material, the core being surrounded by an inner coat of a water-insoluble or relatively water-insoluble coating material in which particulate water-insoluble material is embedded. The inner coat is additionally surrounded by an outer coat that contains additional amounts of the desired agent. When the delivery device enters the gastrointestinal tract, the outer coat releases the desired agent contained therein and disintegrates, exposing the inner coat. The particulate matter in the inner coat takes up liquid, thus forming channels interconnecting the drug-containing core with the outside of the delivery device. Through these channels liquid enters the core which then swells to the point at which the inner coat is broken. When the integrity of the inner coat is destroyed, the core then disintegrates, immediately releasing all or most of the drug at a specific site.
    Type: Application
    Filed: June 4, 1999
    Publication date: August 15, 2002
    Inventors: ADEL PENHASI, MOSHE FLASHNER, E. ITZHAK LERNER
  • Publication number: 20010024657
    Abstract: The invention is directed to a controlled-release solid composition for the oral cavity or “pharmaceutical oral patch” that adheres to hard dental surfaces, such as teeth and dentures, and releases an active pharmaceutical agent into the oral cavity. Release of the agent is for a predetermined period of time and at a predetermined sustained concentration. The site of action of the agent is local or systemic.
    Type: Application
    Filed: January 31, 2001
    Publication date: September 27, 2001
    Inventors: E. Itzhak Lerner, Vered Rosenberger, Moshe Flashner
  • Patent number: 6231888
    Abstract: A composition and method for the treatment of polyp and colon cancer is described, such composition and method providing for the colonic delivery and/or preferential metabolism of a drug or desired agent, especially an NSAID, in the colon of the patient in need such treatment.
    Type: Grant
    Filed: November 12, 1998
    Date of Patent: May 15, 2001
    Assignee: Perio Products Ltd.
    Inventors: E. Itzhak Lerner, Moshe Flashner, Adel Penhasi
  • Patent number: 6197331
    Abstract: The invention is directed to a controlled-release solid composition for the oral cavity or “pharmaceutical oral patch” that adheres to hard dental surfaces, such as teeth and dentures, and releases an active pharmaceutical agent into the oral cavity. Release of the agent is for a predetermined period of time and at a predetermined sustained concentration. The site of action of the agent is local or systemic.
    Type: Grant
    Filed: July 24, 1997
    Date of Patent: March 6, 2001
    Assignee: Perio Products Ltd.
    Inventors: E. Itzhak Lerner, Vered Rosenberger, Moshe Flashner
  • Patent number: 5840332
    Abstract: A gastrointestinal delivery system is provided. The system comprises a drug in combination with a core material, the core being surrounded by a water-insoluble or relatively water-insoluble coating material in which particulate water-insoluble material is embedded. When the delivery device enters the gastrointestinal tract, the particulate matter takes up liquid, thus forming channels interconnecting the drug-containing core with the outside of the delivery device. These channels allow the release of drug from the core into the gastrointestinal tract. By controlling parameters in the device, such as the core material, carrier material in the coating, and particulate matter, the location of release of the drug can be carefully controlled. Thus, the invention is also directed to a method of using the device for the treatment of disease by the release of drugs in the gastrointestinal tract in a location- and time- dependent manner.
    Type: Grant
    Filed: January 18, 1996
    Date of Patent: November 24, 1998
    Assignee: Perio Products Ltd.
    Inventors: E. Itzhak Lerner, Moshe Flashner, Adel Penhasi